From GlobeNewswire: 2024-06-07 16:01:00

Anika Therapeutics, Inc. announced granting stock options and restricted stock units to new CFO Stephen Griffin. Options cover 96,525 shares at $29.35 per share, vesting over three years, while RSUs cover 38,520 shares. Both grants were made as inducements to Griffin’s employment acceptance. The options will expire on the tenth anniversary from the grant date. Anika focuses on early intervention orthopedic care, offering minimally invasive products in various orthopedic spaces. This global company is headquartered in Bedford, Massachusetts. For more information, visit www.anika.com. Contact [email protected] for investor inquiries.



Read more at GlobeNewswire: Anika Reports Inducement Grants Under Nasdaq Listing Rule